September 16, 2024

Breast Cancer Research at ESMO Congress 2024

The ESMO Congress 2024 is currently underway in Barcelona, serving as a global hub for the latest advancements in oncology. Researchers, healthcare professionals, and press representatives from around the world have gathered to discuss cutting-edge data and emerging hot topics in cancer care. This year, some of the most compelling findings offer new hope for individuals impacted by breast cancer, especially those dealing with more aggressive forms of the disease.

KEYTRUDA’s Role in Triple-Negative Breast Cancer (TNBC)

A key highlight from the congress is the focus on treatments for aggressive cancers like triple-negative breast cancer (TNBC). KEYTRUDA, a prescription immunotherapy, is showing proven results when used alongside chemotherapy for TNBC patients with stage II and III disease. This marks an important step forward in reducing the risk of cancer returning. Ongoing studies are crucial in understanding how therapies like immunotherapy can improve survival rates and quality of life for patients with TNBC and other breast cancer subtypes.

Breastfeeding After Breast Cancer

Another critical research question answered from the ESMO Congress 2024 involves the safety of breastfeeding after early stage breast cancer diagnosis and treatment, where a mastectomy was not required. Two international studies have provided the first evidence suggesting that breastfeeding does not increase the risk of cancer recurrence or the development of new breast cancers in women previously treated for the disease. This finding is significant, as it addresses a major concern for young survivors that had a lumpectomy and additional cancer treatment who wish to breastfeed their children. Knowing that breastfeeding is both feasible and safe after a diagnosis and treatment for breast cancer can greatly enhance the quality of life for early stage, pre-menopausal survivors, offering more choices in their post-treatment lives.

As the ESMO Congress 2024 continues, the global oncology community remains focused on advancing research, improving treatments, and ultimately improving outcomes for all those affected by breast cancer. These findings represent just a snapshot of the progress being made in research, with more developments on the horizon.

Stay tuned for more updates from Breast Cancer Canada as we continue to bring you the latest from ESMO Congress 2024.

Queens Park: Breast Cancer Canada Calls on Ontarians

Self-Refer for Mammograms as Screening Age Lowers to 40 This pivotal change expands access to life-saving mammograms for millions of women in Ontario, empowering them

Cortney & Connie: Twin sisters carrying the BRCA2 Gene

This year alone, more than 30,000 Canadians are expected to be diagnosed with breast cancer. My journey began in 2015, when I was just 29

Manitoba removing barriers for breast screening

Manitoba is taking a significant step forward in breast cancer care with a new plan to lower the age for self-referral mammogram screenings. Currently, women

New Survey Reveals 94% of Canadians Back Earlier Screening

A Call for Equitable Access to Breast Cancer Care Nationwide Today, Breast Cancer Canada (BCC), a national charity dedicated to saving lives through breast cancer

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.